Reports

Industry Research Reports

Global Antiviral and Antibacterial Textiles Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Antiviral and Antibacterial Textiles Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 203 Pages

Report ld: 4867713

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Antiviral and Antibacterial Textiles market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.

From a downstream perspective, Daily Necessity accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Antiviral and Antibacterial Textiles leading manufacturers including Foss Manufacturing, Acordis, Fuji, Trevira GmbH, Sotexpro, Toray, BioCote, Milliken & Company, UNITIKA, PurThread Technologies, etc., dominate supply; the top five capture approximately % of global revenue, with Foss Manufacturing leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Antiviral and Antibacterial Textiles market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Foss Manufacturing
  • Acordis
  • Fuji
  • Trevira GmbH
  • Sotexpro
  • Toray
  • BioCote
  • Milliken & Company
  • UNITIKA
  • PurThread Technologies
  • NBC Meshtec
  • Microban
  • Sanitized AG
  • Noble Biomaterials
  • HeiQ Materials AG
  • Teijin
  • Nippon Shokubai
  • BASF
  • Murata
  • Dow
  • ANNIL
  • Bioserica Era
  • Qianhai Guangda
  • Ruyi Woolen Garment Group
  • Jiangsu Jonnyma New Materials
  • Zhong Wang Fabric
  • Taihua New Material
  • Lu Thai Textile
  • Fynex Textile

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Inorganic
  • Organic

Segment by Application

  • Daily Necessity
  • Clothing
  • Medical
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Antiviral and Antibacterial Textiles study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Antiviral and Antibacterial Textiles: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Antiviral and Antibacterial Textiles Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Inorganic

1.2.3 Organic

1.3 Market Segmentation by Application

1.3.1 Global Antiviral and Antibacterial Textiles Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Daily Necessity

1.3.3 Clothing

1.3.4 Medical

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Antiviral and Antibacterial Textiles Revenue Estimates and Forecasts 2020-2031

2.2 Global Antiviral and Antibacterial Textiles Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Antiviral and Antibacterial Textiles Sales Estimates and Forecasts 2020-2031

2.4 Global Antiviral and Antibacterial Textiles Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global Antiviral and Antibacterial Textiles Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global Antiviral and Antibacterial Textiles Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Antiviral and Antibacterial Textiles Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Inorganic Market Size by Manufacturers

4.5.2 Organic Market Size by Manufacturers

4.6 Global Antiviral and Antibacterial Textiles Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global Antiviral and Antibacterial Textiles Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Antiviral and Antibacterial Textiles Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global Antiviral and Antibacterial Textiles Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Antiviral and Antibacterial Textiles Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)

7.4 North America Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Antiviral and Antibacterial Textiles Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)

8.4 Europe Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Antiviral and Antibacterial Textiles Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Antiviral and Antibacterial Textiles Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)

10.4 Central and South America Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Antiviral and Antibacterial Textiles Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Antiviral and Antibacterial Textiles Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 Foss Manufacturing

12.1.1 Foss Manufacturing Corporation Information

12.1.2 Foss Manufacturing Business Overview

12.1.3 Foss Manufacturing Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.1.4 Foss Manufacturing Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Product in 2024

12.1.6 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Application in 2024

12.1.7 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024

12.1.8 Foss Manufacturing Antiviral and Antibacterial Textiles SWOT Analysis

12.1.9 Foss Manufacturing Recent Developments

12.2 Acordis

12.2.1 Acordis Corporation Information

12.2.2 Acordis Business Overview

12.2.3 Acordis Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.2.4 Acordis Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Acordis Antiviral and Antibacterial Textiles Sales by Product in 2024

12.2.6 Acordis Antiviral and Antibacterial Textiles Sales by Application in 2024

12.2.7 Acordis Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024

12.2.8 Acordis Antiviral and Antibacterial Textiles SWOT Analysis

12.2.9 Acordis Recent Developments

12.3 Fuji

12.3.1 Fuji Corporation Information

12.3.2 Fuji Business Overview

12.3.3 Fuji Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.3.4 Fuji Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Fuji Antiviral and Antibacterial Textiles Sales by Product in 2024

12.3.6 Fuji Antiviral and Antibacterial Textiles Sales by Application in 2024

12.3.7 Fuji Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024

12.3.8 Fuji Antiviral and Antibacterial Textiles SWOT Analysis

12.3.9 Fuji Recent Developments

12.4 Trevira GmbH

12.4.1 Trevira GmbH Corporation Information

12.4.2 Trevira GmbH Business Overview

12.4.3 Trevira GmbH Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.4.4 Trevira GmbH Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Product in 2024

12.4.6 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Application in 2024

12.4.7 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024

12.4.8 Trevira GmbH Antiviral and Antibacterial Textiles SWOT Analysis

12.4.9 Trevira GmbH Recent Developments

12.5 Sotexpro

12.5.1 Sotexpro Corporation Information

12.5.2 Sotexpro Business Overview

12.5.3 Sotexpro Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.5.4 Sotexpro Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Sotexpro Antiviral and Antibacterial Textiles Sales by Product in 2024

12.5.6 Sotexpro Antiviral and Antibacterial Textiles Sales by Application in 2024

12.5.7 Sotexpro Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024

12.5.8 Sotexpro Antiviral and Antibacterial Textiles SWOT Analysis

12.5.9 Sotexpro Recent Developments

12.6 Toray

12.6.1 Toray Corporation Information

12.6.2 Toray Business Overview

12.6.3 Toray Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.6.4 Toray Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Toray Recent Developments

12.7 BioCote

12.7.1 BioCote Corporation Information

12.7.2 BioCote Business Overview

12.7.3 BioCote Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.7.4 BioCote Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 BioCote Recent Developments

12.8 Milliken & Company

12.8.1 Milliken & Company Corporation Information

12.8.2 Milliken & Company Business Overview

12.8.3 Milliken & Company Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.8.4 Milliken & Company Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Milliken & Company Recent Developments

12.9 UNITIKA

12.9.1 UNITIKA Corporation Information

12.9.2 UNITIKA Business Overview

12.9.3 UNITIKA Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.9.4 UNITIKA Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 UNITIKA Recent Developments

12.10 PurThread Technologies

12.10.1 PurThread Technologies Corporation Information

12.10.2 PurThread Technologies Business Overview

12.10.3 PurThread Technologies Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.10.4 PurThread Technologies Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 PurThread Technologies Recent Developments

12.11 NBC Meshtec

12.11.1 NBC Meshtec Corporation Information

12.11.2 NBC Meshtec Business Overview

12.11.3 NBC Meshtec Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.11.4 NBC Meshtec Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 NBC Meshtec Recent Developments

12.12 Microban

12.12.1 Microban Corporation Information

12.12.2 Microban Business Overview

12.12.3 Microban Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.12.4 Microban Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Microban Recent Developments

12.13 Sanitized AG

12.13.1 Sanitized AG Corporation Information

12.13.2 Sanitized AG Business Overview

12.13.3 Sanitized AG Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.13.4 Sanitized AG Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Sanitized AG Recent Developments

12.14 Noble Biomaterials

12.14.1 Noble Biomaterials Corporation Information

12.14.2 Noble Biomaterials Business Overview

12.14.3 Noble Biomaterials Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.14.4 Noble Biomaterials Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Noble Biomaterials Recent Developments

12.15 HeiQ Materials AG

12.15.1 HeiQ Materials AG Corporation Information

12.15.2 HeiQ Materials AG Business Overview

12.15.3 HeiQ Materials AG Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.15.4 HeiQ Materials AG Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.15.5 HeiQ Materials AG Recent Developments

12.16 Teijin

12.16.1 Teijin Corporation Information

12.16.2 Teijin Business Overview

12.16.3 Teijin Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.16.4 Teijin Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.16.5 Teijin Recent Developments

12.17 Nippon Shokubai

12.17.1 Nippon Shokubai Corporation Information

12.17.2 Nippon Shokubai Business Overview

12.17.3 Nippon Shokubai Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.17.4 Nippon Shokubai Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.17.5 Nippon Shokubai Recent Developments

12.18 BASF

12.18.1 BASF Corporation Information

12.18.2 BASF Business Overview

12.18.3 BASF Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.18.4 BASF Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.18.5 BASF Recent Developments

12.19 Murata

12.19.1 Murata Corporation Information

12.19.2 Murata Business Overview

12.19.3 Murata Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.19.4 Murata Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.19.5 Murata Recent Developments

12.20 Dow

12.20.1 Dow Corporation Information

12.20.2 Dow Business Overview

12.20.3 Dow Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.20.4 Dow Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.20.5 Dow Recent Developments

12.21 ANNIL

12.21.1 ANNIL Corporation Information

12.21.2 ANNIL Business Overview

12.21.3 ANNIL Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.21.4 ANNIL Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.21.5 ANNIL Recent Developments

12.22 Bioserica Era

12.22.1 Bioserica Era Corporation Information

12.22.2 Bioserica Era Business Overview

12.22.3 Bioserica Era Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.22.4 Bioserica Era Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.22.5 Bioserica Era Recent Developments

12.23 Qianhai Guangda

12.23.1 Qianhai Guangda Corporation Information

12.23.2 Qianhai Guangda Business Overview

12.23.3 Qianhai Guangda Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.23.4 Qianhai Guangda Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.23.5 Qianhai Guangda Recent Developments

12.24 Ruyi Woolen Garment Group

12.24.1 Ruyi Woolen Garment Group Corporation Information

12.24.2 Ruyi Woolen Garment Group Business Overview

12.24.3 Ruyi Woolen Garment Group Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.24.4 Ruyi Woolen Garment Group Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.24.5 Ruyi Woolen Garment Group Recent Developments

12.25 Jiangsu Jonnyma New Materials

12.25.1 Jiangsu Jonnyma New Materials Corporation Information

12.25.2 Jiangsu Jonnyma New Materials Business Overview

12.25.3 Jiangsu Jonnyma New Materials Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.25.4 Jiangsu Jonnyma New Materials Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.25.5 Jiangsu Jonnyma New Materials Recent Developments

12.26 Zhong Wang Fabric

12.26.1 Zhong Wang Fabric Corporation Information

12.26.2 Zhong Wang Fabric Business Overview

12.26.3 Zhong Wang Fabric Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.26.4 Zhong Wang Fabric Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.26.5 Zhong Wang Fabric Recent Developments

12.27 Taihua New Material

12.27.1 Taihua New Material Corporation Information

12.27.2 Taihua New Material Business Overview

12.27.3 Taihua New Material Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.27.4 Taihua New Material Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.27.5 Taihua New Material Recent Developments

12.28 Lu Thai Textile

12.28.1 Lu Thai Textile Corporation Information

12.28.2 Lu Thai Textile Business Overview

12.28.3 Lu Thai Textile Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.28.4 Lu Thai Textile Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.28.5 Lu Thai Textile Recent Developments

12.29 Fynex Textile

12.29.1 Fynex Textile Corporation Information

12.29.2 Fynex Textile Business Overview

12.29.3 Fynex Textile Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications

12.29.4 Fynex Textile Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.29.5 Fynex Textile Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 Antiviral and Antibacterial Textiles Industry Chain

13.2 Antiviral and Antibacterial Textiles Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Antiviral and Antibacterial Textiles Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Antiviral and Antibacterial Textiles Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 Antiviral and Antibacterial Textiles Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global Antiviral and Antibacterial Textiles Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Antiviral and Antibacterial Textiles Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Antiviral and Antibacterial Textiles Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Antiviral and Antibacterial Textiles Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Antiviral and Antibacterial Textiles Sales by Region (2020-2025) & (Tons)
Table 8. Global Antiviral and Antibacterial Textiles Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Antiviral and Antibacterial Textiles Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Antiviral and Antibacterial Textiles Production by Region (2020-2025) & (Tons)
Table 12. Global Antiviral and Antibacterial Textiles Production by Region (2026-2031) & (Tons)
Table 13. Global Antiviral and Antibacterial Textiles Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Antiviral and Antibacterial Textiles Sales Share by Manufacturers (2020-2025)
Table 15. Global Antiviral and Antibacterial Textiles Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Antiviral and Antibacterial Textiles Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Antiviral and Antibacterial Textiles by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral and Antibacterial Textiles as of 2024)
Table 19. Global Antiviral and Antibacterial Textiles Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Antiviral and Antibacterial Textiles Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Antiviral and Antibacterial Textiles Manufacturing Base and Headquarters
Table 22. Global Antiviral and Antibacterial Textiles Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Antiviral and Antibacterial Textiles Sales by Type (2020-2025) & (Tons)
Table 26. Global Antiviral and Antibacterial Textiles Sales by Type (2026-2031) & (Tons)
Table 27. Global Antiviral and Antibacterial Textiles Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Antiviral and Antibacterial Textiles Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Antiviral and Antibacterial Textiles ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Antiviral and Antibacterial Textiles Sales by Application (2020-2025) & (Tons)
Table 32. Global Antiviral and Antibacterial Textiles Sales by Application (2026-2031) & (Tons)
Table 33. Antiviral and Antibacterial Textiles High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Antiviral and Antibacterial Textiles Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Antiviral and Antibacterial Textiles Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Antiviral and Antibacterial Textiles ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Antiviral and Antibacterial Textiles Growth Accelerators and Market Barriers
Table 40. North America Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Antiviral and Antibacterial Textiles Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Antiviral and Antibacterial Textiles Growth Accelerators and Market Barriers
Table 43. Europe Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Antiviral and Antibacterial Textiles Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Antiviral and Antibacterial Textiles Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Antiviral and Antibacterial Textiles Growth Accelerators and Market Barriers
Table 48. Southeast Asia Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Antiviral and Antibacterial Textiles Investment Opportunities and Key Challenges
Table 50. Central and South America Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Antiviral and Antibacterial Textiles Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Foss Manufacturing Corporation Information
Table 54. Foss Manufacturing Description and Major Businesses
Table 55. Foss Manufacturing Product Models, Descriptions and Specifications
Table 56. Foss Manufacturing Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Foss Manufacturing Sales Value Proportion by Product in 2024
Table 58. Foss Manufacturing Sales Value Proportion by Application in 2024
Table 59. Foss Manufacturing Sales Value Proportion by Geographic Area in 2024
Table 60. Foss Manufacturing Antiviral and Antibacterial Textiles SWOT Analysis
Table 61. Foss Manufacturing Recent Developments
Table 62. Acordis Corporation Information
Table 63. Acordis Description and Major Businesses
Table 64. Acordis Product Models, Descriptions and Specifications
Table 65. Acordis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Acordis Sales Value Proportion by Product in 2024
Table 67. Acordis Sales Value Proportion by Application in 2024
Table 68. Acordis Sales Value Proportion by Geographic Area in 2024
Table 69. Acordis Antiviral and Antibacterial Textiles SWOT Analysis
Table 70. Acordis Recent Developments
Table 71. Fuji Corporation Information
Table 72. Fuji Description and Major Businesses
Table 73. Fuji Product Models, Descriptions and Specifications
Table 74. Fuji Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Fuji Sales Value Proportion by Product in 2024
Table 76. Fuji Sales Value Proportion by Application in 2024
Table 77. Fuji Sales Value Proportion by Geographic Area in 2024
Table 78. Fuji Antiviral and Antibacterial Textiles SWOT Analysis
Table 79. Fuji Recent Developments
Table 80. Trevira GmbH Corporation Information
Table 81. Trevira GmbH Description and Major Businesses
Table 82. Trevira GmbH Product Models, Descriptions and Specifications
Table 83. Trevira GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Trevira GmbH Sales Value Proportion by Product in 2024
Table 85. Trevira GmbH Sales Value Proportion by Application in 2024
Table 86. Trevira GmbH Sales Value Proportion by Geographic Area in 2024
Table 87. Trevira GmbH Antiviral and Antibacterial Textiles SWOT Analysis
Table 88. Trevira GmbH Recent Developments
Table 89. Sotexpro Corporation Information
Table 90. Sotexpro Description and Major Businesses
Table 91. Sotexpro Product Models, Descriptions and Specifications
Table 92. Sotexpro Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Sotexpro Sales Value Proportion by Product in 2024
Table 94. Sotexpro Sales Value Proportion by Application in 2024
Table 95. Sotexpro Sales Value Proportion by Geographic Area in 2024
Table 96. Sotexpro Antiviral and Antibacterial Textiles SWOT Analysis
Table 97. Sotexpro Recent Developments
Table 98. Toray Corporation Information
Table 99. Toray Description and Major Businesses
Table 100. Toray Product Models, Descriptions and Specifications
Table 101. Toray Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Toray Recent Developments
Table 103. BioCote Corporation Information
Table 104. BioCote Description and Major Businesses
Table 105. BioCote Product Models, Descriptions and Specifications
Table 106. BioCote Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. BioCote Recent Developments
Table 108. Milliken & Company Corporation Information
Table 109. Milliken & Company Description and Major Businesses
Table 110. Milliken & Company Product Models, Descriptions and Specifications
Table 111. Milliken & Company Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Milliken & Company Recent Developments
Table 113. UNITIKA Corporation Information
Table 114. UNITIKA Description and Major Businesses
Table 115. UNITIKA Product Models, Descriptions and Specifications
Table 116. UNITIKA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. UNITIKA Recent Developments
Table 118. PurThread Technologies Corporation Information
Table 119. PurThread Technologies Description and Major Businesses
Table 120. PurThread Technologies Product Models, Descriptions and Specifications
Table 121. PurThread Technologies Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. PurThread Technologies Recent Developments
Table 123. NBC Meshtec Corporation Information
Table 124. NBC Meshtec Description and Major Businesses
Table 125. NBC Meshtec Product Models, Descriptions and Specifications
Table 126. NBC Meshtec Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. NBC Meshtec Recent Developments
Table 128. Microban Corporation Information
Table 129. Microban Description and Major Businesses
Table 130. Microban Product Models, Descriptions and Specifications
Table 131. Microban Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. Microban Recent Developments
Table 133. Sanitized AG Corporation Information
Table 134. Sanitized AG Description and Major Businesses
Table 135. Sanitized AG Product Models, Descriptions and Specifications
Table 136. Sanitized AG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. Sanitized AG Recent Developments
Table 138. Noble Biomaterials Corporation Information
Table 139. Noble Biomaterials Description and Major Businesses
Table 140. Noble Biomaterials Product Models, Descriptions and Specifications
Table 141. Noble Biomaterials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. Noble Biomaterials Recent Developments
Table 143. HeiQ Materials AG Corporation Information
Table 144. HeiQ Materials AG Description and Major Businesses
Table 145. HeiQ Materials AG Product Models, Descriptions and Specifications
Table 146. HeiQ Materials AG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. HeiQ Materials AG Recent Developments
Table 148. Teijin Corporation Information
Table 149. Teijin Description and Major Businesses
Table 150. Teijin Product Models, Descriptions and Specifications
Table 151. Teijin Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 152. Teijin Recent Developments
Table 153. Nippon Shokubai Corporation Information
Table 154. Nippon Shokubai Description and Major Businesses
Table 155. Nippon Shokubai Product Models, Descriptions and Specifications
Table 156. Nippon Shokubai Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 157. Nippon Shokubai Recent Developments
Table 158. BASF Corporation Information
Table 159. BASF Description and Major Businesses
Table 160. BASF Product Models, Descriptions and Specifications
Table 161. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 162. BASF Recent Developments
Table 163. Murata Corporation Information
Table 164. Murata Description and Major Businesses
Table 165. Murata Product Models, Descriptions and Specifications
Table 166. Murata Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 167. Murata Recent Developments
Table 168. Dow Corporation Information
Table 169. Dow Description and Major Businesses
Table 170. Dow Product Models, Descriptions and Specifications
Table 171. Dow Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 172. Dow Recent Developments
Table 173. ANNIL Corporation Information
Table 174. ANNIL Description and Major Businesses
Table 175. ANNIL Product Models, Descriptions and Specifications
Table 176. ANNIL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 177. ANNIL Recent Developments
Table 178. Bioserica Era Corporation Information
Table 179. Bioserica Era Description and Major Businesses
Table 180. Bioserica Era Product Models, Descriptions and Specifications
Table 181. Bioserica Era Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 182. Bioserica Era Recent Developments
Table 183. Qianhai Guangda Corporation Information
Table 184. Qianhai Guangda Description and Major Businesses
Table 185. Qianhai Guangda Product Models, Descriptions and Specifications
Table 186. Qianhai Guangda Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 187. Qianhai Guangda Recent Developments
Table 188. Ruyi Woolen Garment Group Corporation Information
Table 189. Ruyi Woolen Garment Group Description and Major Businesses
Table 190. Ruyi Woolen Garment Group Product Models, Descriptions and Specifications
Table 191. Ruyi Woolen Garment Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 192. Ruyi Woolen Garment Group Recent Developments
Table 193. Jiangsu Jonnyma New Materials Corporation Information
Table 194. Jiangsu Jonnyma New Materials Description and Major Businesses
Table 195. Jiangsu Jonnyma New Materials Product Models, Descriptions and Specifications
Table 196. Jiangsu Jonnyma New Materials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 197. Jiangsu Jonnyma New Materials Recent Developments
Table 198. Zhong Wang Fabric Corporation Information
Table 199. Zhong Wang Fabric Description and Major Businesses
Table 200. Zhong Wang Fabric Product Models, Descriptions and Specifications
Table 201. Zhong Wang Fabric Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 202. Zhong Wang Fabric Recent Developments
Table 203. Taihua New Material Corporation Information
Table 204. Taihua New Material Description and Major Businesses
Table 205. Taihua New Material Product Models, Descriptions and Specifications
Table 206. Taihua New Material Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 207. Taihua New Material Recent Developments
Table 208. Lu Thai Textile Corporation Information
Table 209. Lu Thai Textile Description and Major Businesses
Table 210. Lu Thai Textile Product Models, Descriptions and Specifications
Table 211. Lu Thai Textile Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 212. Lu Thai Textile Recent Developments
Table 213. Fynex Textile Corporation Information
Table 214. Fynex Textile Description and Major Businesses
Table 215. Fynex Textile Product Models, Descriptions and Specifications
Table 216. Fynex Textile Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 217. Fynex Textile Recent Developments
Table 218. Key Raw Materials Distribution
Table 219. Raw Materials Key Suppliers
Table 220. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 221. Milestones in Production Technology Evolution
Table 222. Distributors List
Table 223. Market Trends and Market Evolution
Table 224. Market Drivers and Opportunities
Table 225. Market Challenges, Risks, and Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Antiviral and Antibacterial Textiles Product Picture
Figure 2. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Inorganic Product Picture
Figure 4. Organic Product Picture
Figure 5. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Daily Necessity
Figure 7. Clothing
Figure 8. Medical
Figure 9. Others
Figure 10. Antiviral and Antibacterial Textiles Report Years Considered
Figure 11. Global Antiviral and Antibacterial Textiles Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 13. Global Antiviral and Antibacterial Textiles Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Antiviral and Antibacterial Textiles Revenue Market Share by Region (2020-2031)
Figure 15. Global Antiviral and Antibacterial Textiles Sales (2020-2031) & (Tons)
Figure 16. Global Antiviral and Antibacterial Textiles Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Antiviral and Antibacterial Textiles Sales Market Share by Region (2020-2031)
Figure 18. Global Antiviral and Antibacterial Textiles Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Antiviral and Antibacterial Textiles Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Antiviral and Antibacterial Textiles Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Antiviral and Antibacterial Textiles Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Antiviral and Antibacterial Textiles Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Antiviral and Antibacterial Textiles Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Antiviral and Antibacterial Textiles Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Antiviral and Antibacterial Textiles Sales Volume Market Share in 2024
Figure 27. Global Antiviral and Antibacterial Textiles Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Inorganic Revenue Market Share by Manufacturer in 2024
Figure 30. Organic Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Antiviral and Antibacterial Textiles Sales Market Share by Type (2020-2031)
Figure 34. Global Antiviral and Antibacterial Textiles Revenue Market Share by Type (2020-2031)
Figure 35. Global Antiviral and Antibacterial Textiles Sales Market Share by Application (2020-2031)
Figure 36. Global Antiviral and Antibacterial Textiles Revenue Market Share by Application (2020-2031)
Figure 37. North America Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
Figure 38. North America Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
Figure 40. North America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2020- 2031)
Figure 41. North America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
Figure 43. North America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
Figure 48. Europe Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
Figure 50. Europe Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2020-2031)
Figure 51. Europe Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
Figure 53. Europe Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 55. France Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
Figure 60. Asia-Pacific Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2020- 2031)
Figure 63. Asia-Pacific Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
Figure 65. Asia-Pacific Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 70. India Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
Figure 72. Central and South America Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2021-2031)
Figure 75. Central and South America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
Figure 77. Central and South America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
Figure 81. Middle East and Africa Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2021-2031)
Figure 84. South America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
Figure 86. Middle East and Africa Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
Figure 91. Antiviral and Antibacterial Textiles Industry Chain Mapping
Figure 92. Regional Antiviral and Antibacterial Textiles Manufacturing Base Distribution (%)
Figure 93. Antiviral and Antibacterial Textiles Production Process
Figure 94. Regional Antiviral and Antibacterial Textiles Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Antiviral and Antibacterial Textiles market?zhanKai
The top companies in the global Antiviral and Antibacterial Textiles market are Foss Manufacturing、Acordis、Fuji.
den_biaoTiZhungShi

Related Reports

Global Antiviral and Antibacterial Textiles Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-08-05

Pages: 203 Pages

Report ld: 4867713

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now